Upgrade to SI Premium - Free Trial

Piper Sandler Starts Relmada Therapeutics Inc (RLMD) at Overweight

March 24, 2026 3:59 AM
Piper Sandler analyst Kelsey Goodwin initiates coverage on Relmada Therapeutics Inc (NASDAQ: RLMD) with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage